Tailored organoid may help unravel immune response mystery

Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.

Softening of tumor tissue could aid in cancer drug delivery

A Cornell research group reports that a mechanical factor - stiffening of a cancer cell and its matrix - and not a chemical cause could contribute to metastasis in some forms of cancer.

As routine screenings drop, prostate cancer on rise in older men

The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.

Research reveals codes that control protein expression

Scientists from Weill Cornell Medicine discovered an internal code in cellular molecules, called messenger RNA, predetermines how much protein they will produce.

New model could benefit liver cancer transplant patients

A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.

Dr. Henry Heimlich, inventor of lifesaving maneuver, dies at 96

Dr. Henry Heimlich '41, M.D. '43, creator of the life-saving Heimlich maneuver, died Dec. 17 in Cincinnati at the age of 96.

Diagnosing, treating 'superbugs' is goal of NYC-Ithaca team

Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.

Compound protects transplanted hearts from rejection

An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice, says new research from scientists at Weill Cornell Medicine.

Study tracks stroke victim's restored communication ability

A Weill Cornell Medicine study published Dec. 7 represents the first time scientists have captured the restoration of communication of a minimally conscious patient by measuring aspects of brain structure and function.